Key result
Point-of-care devices for assessing antiplatelet drugs are promising but not as sensitive as laboratory platelet aggregometry, and global assessments lack specificity for platelet function.
Why the study?
How do point-of-care techniques compare to laboratory aggregometry in detecting antiplatelet drug effects in the perioperative period?
How do point-of-care techniques compare to laboratory aggregometry in detecting antiplatelet drug effects in the perioperative period?
Point-of-care platelet function tests have limited sensitivity compared to laboratory aggregometry for detecting antiplatelet drug effects, which must be considered during perioperative clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Point-of-care platelet testing warrants cautious perioperative interpretation due to lower sensitivity; leaves open need for validated standardized protocols.
N. M. Gibbs (2009) conducted a review in Antiplatelet drug effects in the perioperative period. Point-of-care techniques for detection of antiplatelet drug effects vs. Laboratory platelet aggregometry was evaluated on Sensitivity and specificity for platelet function and antiplatelet drugs. Point-of-care devices for assessing antiplatelet drugs are promising but not as sensitive as laboratory platelet aggregometry, and global assessments lack specificity for platelet function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: